Fleury SA operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other
pharmaceutical manufacturers in Latin America:
Instituto Hermes Pardini SA
sales of 1.49 billion Brazilian Reals [US$266.07 million]
of which 100%
was auxiliary diagnostic support services),
Ouro Fino Saude Animal Participacoes SA
(730.11 million Brazilian Reals [US$130.02 million]
of which 74%
was Production Animals), and
(4.09 billion Brazilian Reals [US$728.19 million]
During the year ended December of 2020, sales at
Fleury SA were 2.97 billion Brazilian Reals (US$529.22 million).
increase of 2.3%
versus 2019, when the company's sales were 2.91 billion Brazilian Reals.
This was the fifth consecutive year of sales increases at Fleury SA
(and since 2015, sales have increased a total of 57%).
Sales of Integrated Medicine saw an increase
that was more than double the company's growth rate: sales were up
15.3% in 2020, from
467.62 million Brazilian Reals to 538.93 million Brazilian Reals.
Not all segments of Fleury SA experienced an increase in sales in 2020:
sales of Diagnostic Medicine fell 0.2% to 2.43 billion Brazilian Reals.